Beamtx.com Website Review

beam is pioneering the use of crispr base editing to treat disease, one letter at a time. the human genome is made up of billions of nucleobases, or “bases,” represented by the letters a, g, t, and c. beam’s base editing technology can precisely target and make specific edits to a single base in dna or rna, without cutting or disrupting the gene. base editors have the potential to repair disease-causing point mutations, write in protective genetic variations, or modulate the expression or function of disease-causing genes. beam is committed to developing base editors as a new clas* of precision genetic medicines that can treat or cure diseases affecting patients’ lives. our search for the next generation of scientific superstars had... fiercebiotech names beam thera*eutics as one of its “fierce 15” biotech companies of 2018. cambridge, mas*. – beam thera*eutics, a biotechnology company developing precision.. starting with our founders and funders, we’re building a world-clas* team to develop precision genetic medicines through dna and rna base. senior research as*ociate, rna editing & novel crispr nucleases. beam is looking for a highly motivated and experienced research as*ociate to support our rna editing & novel crispr nucleasesread more the formulation development group at beam is seeking several highly motivated scientists to join the team. these research as*ociates we are looking for a highly motivated and creative scientist with expertise in the cell and gene therapy space toread more this field is for validation purposes and should be left unchanged. this iframe contains the logic required to handle ajax powered gravity forms.